Merck lifts full-year forecast as Keytruda sales soar

Go back to Merck lifts full-year forecast as Keytruda sales soar
Merck & Co. (NYSE: MRK) Delayed: 129.13 +0.47 (0.37%)
Previous Close $128.66    52 Week High $65.46 
Open $127.65    52 Week Low $47.97 
Day High $129.24    P/E 87.84 
Day Low $126.74    EPS $1.47 
Volume 4,027,346